> Endo Pharmaceutical is buying Novartis' Voltaren gel for $85 million upfront and a one-time sales milestone of $25 million. Release
> Researchers for Microbia and Forest Laboratories have produced positive Phase II data from two studies of linaclotide in patients with chronic constipation as well as patients with irritable bowel syndrome with constipation. Release
> MorphoSys has inked a deal to supply genetically engineered antibodies to Spain's Proteomika SL for use in research into diagnostics and novel treatments. Release
> After some arm-twisting from the FDA, Roche has added stronger warnings to its Tamiflu label. Report
> A new study shows that costlier drugs may work better. Report
> Another prominent South Korean biomedical researcher stands accused of faking data that appeared in prestigious scientific journals. Report
> Leaders in the nanotech field have been beating a path to Congress, asking lawmakers to significantly boost federal support of research into molecular-level advances. Report
> Hormones produced by the heart could play a remarkable role in controlling and perhaps even curing cancer. Report
> Forget those studies of long-lived Italian shepherds and Greek fishermen. It's not fresh air or exercise or a simple whole-foods diet that causes certain people to live past 100, a new study shows. Instead, it's a set of genetic mutations thought to interfere with normal cell growth and thus slow aging. Report
And Finally... Several of the world's top biomedical research institutes--including a couple run by biopharma giants--have made this year's list of the best places for postdocs to work. Report